Zhenkun Ma is the founder of TenNor Therapeutics. TenNor Therapeutics has raised $109M in total funding. Latest round: Series B. Based in Suzhou, China.
Zhenkun Ma is the Founder and CEO of TenNor Therapeutics, a clinical-stage Chinese company established in 2013 in Suzhou. The company focuses on developing dual-acting antibiotics for infectious diseases, with its most advanced product, TNP-2092 oral capsule, targeting gastrointestinal tract infections. TenNor Therapeutics has secured a $25 million Series B financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library